CENCORA, INC. Discontinued Operation, Tax Effect of Discontinued Operation
CENCORA, INC. (COR) reported Discontinued Operation, Tax Effect of Discontinued Operation of $0 for the 12-month period ending 2014-09-30, per its 10-K filed 2015-11-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation · last filed 2015-11-24
- CENCORA, INC. discontinued operation, tax effect of discontinued operation for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- CENCORA, INC. discontinued operation, tax effect of discontinued operation for fiscal 2013 was $9.64M, a 99.09% increase from fiscal 2012.
- CENCORA, INC. discontinued operation, tax effect of discontinued operation for fiscal 2012 was $4.84M, a 37.41% increase from fiscal 2011.
- CENCORA, INC. discontinued operation, tax effect of discontinued operation for fiscal 2011 was $3.52M.
| Period end | Discontinued Operation, Tax Effect of Discontinued Operation 12 month | Discontinued Operation, Tax Effect of Discontinued Operation 12 month as first filed |
|---|---|---|
| 2014-09-30 | $0.00 10-K · filed 2015-11-24 | |
| 2013-09-30 | $9.64M 10-K · filed 2015-11-24 | |
| 2012-09-30 | $4.84M 10-K · filed 2014-11-25 | $5.41M 10-K · filed 2012-11-27 |
| 2011-09-30 | $3.52M 10-K · filed 2013-11-26 | $0.00 10-K · filed 2011-11-22 |
| 2010-09-30 | $5.78M 8-K · filed 2013-07-16 | $0.00 10-K · filed 2011-11-22 |
| 2009-09-30 | $353.00K 10-K · filed 2011-11-22 | |
| 2008-09-30 | $2.15M 10-K · filed 2010-11-23 | |
| 2007-09-30 | $10.29M 10-K · filed 2009-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |